Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid + chondroitin sulfate versus fosfomycin trometamol for prevention of recurrent urinary tract infection
2014-000906-36Phase 4Terminated
- Sponsor
- Gebro Pharma
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in urinary tract infection (UTI) comparing Hyaluronic acid + chondroitin sulfate with Fosfomycin trometamol (2 arms). Primary endpoint: Time to recurrence of infection. Started Oct 2014; status: terminated.
02
Drugs
hyaluronic acidchondroitin sulfatefosfomycin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2014-000906-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000906-36.